TESARO Announces Participation at Goldman Sachs 38th Annual Global Healthcare Conference
June 07 2017 - 04:30PM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, today announced its participation at the Goldman Sachs
38th Annual Global Healthcare Conference, to be held June 13-15,
2017 at the Terranea Resort in Rancho Palos Verdes,
California. Tim Pearson, EVP and CFO of TESARO, will present at
10:40 AM PT on June 15 and will participate in meetings with
investors.
A live webcast of the presentation will be
available by visiting the Investors section of the TESARO website
at www.tesarobio.com. An archived replay of this webcast will
be available on the Company’s website for 14 days following the
conferences.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
For additional information, please contact:
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2023 to Mar 2024